Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras. [electronic resource]
Producer: 20170829Description: 1335-43 p. digitalISSN:- 1476-5551
- Animals
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Indazoles
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- MAP Kinase Signaling System
- Mice
- Myelodysplastic Syndromes -- drug therapy
- Myeloproliferative Disorders -- drug therapy
- Phosphatidylinositol 3-Kinases -- drug effects
- Proto-Oncogene Proteins c-akt -- drug effects
- Signal Transduction -- drug effects
- Sulfonamides
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.